[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339880-105":59,"doc-detail-339880-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","squamous-cell-carcinoma-in-never-smokers-an-insight-into-smarcb1-loss","Squamous Cell Carcinoma in Never Smokers: An Insight into SMARCB1 Loss","","Lung cancer remains the leading cause of cancer-related mortality, with non-small cell lung cancer (NSCLC) forming 85% of cases. Squamous cell carcinoma is strongly linked to smoking, yet lung cancer in never smokers (LCINS) accounts for ~25% and is rising, particularly in East Asia. LCINS-squamous cell carcinoma is poorly defined genetically, motivating a UK retrospective cohort of 59 patients treated by radical resection and profiled using tumor sequencing to determine genomic aberrations and survival outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/squamous-cell-carcinoma-in-never-smokers-an-insight-into-smarcb1-loss/339880/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/squamous-cell-carcinoma-in-never-smokers-an-insight-into-smarcb1-loss/339880.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main focus regarding lung cancer in never smokers?","Question",{"text":112,"@type":113},"The study examines lung cancer in never smokers with squamous cell carcinoma and investigates how SMARCB1 loss and related genomic alterations affect clinical outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was patient data collected and what treatments were involved?",{"text":117,"@type":113},"A retrospective review over July 2003–July 2023 included 59 patients with LCINS-squamous cell carcinoma who underwent radical surgical resection.",{"name":119,"@type":110,"acceptedAnswer":120},"What did molecular analysis show about SMARCB1 loss in a subset of patients?",{"text":121,"@type":113},"Molecular analysis identified biallelic SMARCB1 loss in two younger patients, associated with rapid disease progression despite R0 resection.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339880,1790322738,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Communication  \nSquamous Cell Carcinoma in Never Smokers: An Insight into SMARCB1 Loss  \nAkshay J. Patel 1,2,*, Hanan Hemead 2, Hannah Jesani 2, Andrea Bille 3, Philippe Taniere 4 and Gary Middleton 1  \nCitation: Patel, A.J.; Hemead, H.; Jesani, H.; Bille, A.; Taniere, P.; Middleton, G. Squamous Cell Carcinoma in Never Smokers: An Insight into SMARCB1 Loss. Int. J. Mol. Sci. 2024, 25, 8165. [https://](https://)[ ](https://)[doi.org/10.3390/ijms25158165](doi.org/10.3390/ijms25158165)  \nAcademic Editor: Domenico Galati  \nReceived: 9 July 2024  \nRevised: 22 July 2024  \nAccepted: 24 July 2024  \nPublished: 26 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Vincent Drive, Edgbaston, Birmingham B15 2TT, UK; [g.middleton@bham.ac.uk](g.middleton@bham.ac.uk)  \n2 Department of Thoracic Surgery, University Hospitals Birmingham, Birmingham B15 2GW, UK; [hanan.hemead@nhs.net](hanan.hemead@nhs.net) (H.H.); [hannah.jesani@nhs.net](hannah.jesani@nhs.net) (H.J.)  \n3 Department of Thoracic Surgery, Guy’s Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London SE1 9RT, UK; [andrea.bille@nhs.net](andrea.bille@nhs.net)  \n4 Department of Cellular Histopathology, University Hospitals Birmingham, Birmingham B15 2GW, UK; [philippe.taniere@uhb.nhs.uk](philippe.taniere@uhb.nhs.uk)  \n* Correspondence: [a.patel.2@bham.ac.uk](a.patel.2@bham.ac.uk); Tel.: +44-0121-414-3344  \nAbstract: Lung cancer remains the leading cause of cancer-related mortality worldwide, with nonsmall cell lung cancer (NSCLC) constituting 85% of cases. Among NSCLCs, squamous cell carcinoma (SqCC) is strongly associated with smoking. However, lung cancer in never smokers (LCINS) represents approximately 25% of lung cancer cases globally and shows increasing incidence, particularly in East Asia. LCINS-SqCC is less well-characterized, especially regarding its genomic alterationsand their impact on clinical outcomes. We conducted a retrospective analysis over a 20-year period (July 2003–July 2023) at two major tertiary centers in the UK. The cohort included 59 patients with LCINS-SqCC who underwent radical surgical resection. Data collected included demographic information, comorbidities, histopathological details, and outcome metrics such as disease-free and overall survival. Molecular sequencing of tumor specimens was performed to identify genomic aberrations. The cohort had a median age of 71 years (IQR 62–77) and a median BMI of 25.4 (IQR 22.8–27.8), with a slight male predominance (53%) . The majority of patients (93%) had a preoperative MRC of 1–2 . Recurrent disease was observed in 23 patients (39%), and 32 patients (54%) had died at a median follow-up of 3 years. Median disease-free survival was 545 days (IQR 132–1496), and overall survival was 888 days (IQR 443–2071) . Preoperative creatinine levels were higher in patients who experienced recurrence (p = 0.037) . Molecular analysis identified biallelic SMARCB1 loss in two younger patients, associated with rapid disease progression despite R0 resection. These patients’ tumors were PDL1-negative, TTF-1-negative, and positive for cytokeratin, CD56, and p40 . SMARCB1-deficient SqCC in never smokers represents a highly aggressive variant with poor disease-free survival, highlighting the importance of integrating advanced molecular diagnostics in clinical practice. This study underscores the necessity for personalized treatment strategies, including targeted therapies such as EZH2 inhibitors and immune checkpoint blockade, to address the unique molecular pathways in SMARCB1-deficient cancers. Further clin","cbCaipqpy7cgRDRf","https://ap.wps.com/l/cbCaipqpy7cgRDRf","pdf",2780202,"English","# Abstract\n# Introduction","[{\"question\":\"What is the study’s main focus regarding lung cancer in never smokers?\",\"answer\":\"The study examines lung cancer in never smokers with squamous cell carcinoma and investigates how SMARCB1 loss and related genomic alterations affect clinical outcomes.\"},{\"question\":\"How was patient data collected and what treatments were involved?\",\"answer\":\"A retrospective review over July 2003–July 2023 included 59 patients with LCINS-squamous cell carcinoma who underwent radical surgical resection.\"},{\"question\":\"What did molecular analysis show about SMARCB1 loss in a subset of patients?\",\"answer\":\"Molecular analysis identified biallelic SMARCB1 loss in two younger patients, associated with rapid disease progression despite R0 resection.\"}]","Squamous Cell Carcinoma in Never Smokers: An Insight into SMARCB1 Loss | PDF",1790032904,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f9344a491c34046118815c9c95a191f7.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac7f86e096cadc95cb332576b26664e0.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af00dec529763cb86b7028c0d2cee681.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e362c893518bc331021bc882d24a0959.webp",980,1385]